ANALISIS KINERJA KEUANGAN PERUSAHAAN PT.INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK

Erny Setyowati, S. Dwiningsih, Ike Ratnasari
{"title":"ANALISIS KINERJA KEUANGAN PERUSAHAAN PT.INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK","authors":"Erny Setyowati, S. Dwiningsih, Ike Ratnasari","doi":"10.32815/ristansi.v2i2.450","DOIUrl":null,"url":null,"abstract":"Abstract \nIt is important to assess the company's financial performance to assist management and investors in making decisions. One method to analyze the company's financial performance assessment is using the Economic Value Added (EVA) analysis method. EVA is an analytical method to determine the company's added value by subtracting economic profit from the cost of capital issued. EVA method analysis begins by calculating Net Operating Profit After Tax (NOPAT), Invest Capital (IC), Weighted Average Cost of Capital (WACC), Capital Charge (CC) and Economic Value Added (EVA). This study aims to assess the financial performance of PT. Sido Muncul's Herbal and Pharmaceutical Industry, 2017-2019 using the Economic Value Added (EVA) analysis method. This research is descriptive and uses a quantitative approach. The data in this study are financial statements, namely balance sheets and income statements. From the results of the study, the EVA value during the research year increased and was positive (EVA > 0). This shows that PT. The Herbal and Pharmaceutical Industry of Sido Muncul Tbk is able to create added economic value for management and investors (shareholders). After being compared with similar companies, the EVA value which occupies the highest position is PT. Kalbe Farma Tbk, then the next sequence is PT. Herbal and Pharmaceutical Industry Sido Muncul Tbk and the last one is PT Darya-Varia Laboratoria Tbk. \n \nKeywords: Financial statement analysis, NOPAT, IC, WACC, CC and EVA","PeriodicalId":321219,"journal":{"name":"RISTANSI: Riset Akuntansi","volume":"11 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"RISTANSI: Riset Akuntansi","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.32815/ristansi.v2i2.450","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Abstract It is important to assess the company's financial performance to assist management and investors in making decisions. One method to analyze the company's financial performance assessment is using the Economic Value Added (EVA) analysis method. EVA is an analytical method to determine the company's added value by subtracting economic profit from the cost of capital issued. EVA method analysis begins by calculating Net Operating Profit After Tax (NOPAT), Invest Capital (IC), Weighted Average Cost of Capital (WACC), Capital Charge (CC) and Economic Value Added (EVA). This study aims to assess the financial performance of PT. Sido Muncul's Herbal and Pharmaceutical Industry, 2017-2019 using the Economic Value Added (EVA) analysis method. This research is descriptive and uses a quantitative approach. The data in this study are financial statements, namely balance sheets and income statements. From the results of the study, the EVA value during the research year increased and was positive (EVA > 0). This shows that PT. The Herbal and Pharmaceutical Industry of Sido Muncul Tbk is able to create added economic value for management and investors (shareholders). After being compared with similar companies, the EVA value which occupies the highest position is PT. Kalbe Farma Tbk, then the next sequence is PT. Herbal and Pharmaceutical Industry Sido Muncul Tbk and the last one is PT Darya-Varia Laboratoria Tbk. Keywords: Financial statement analysis, NOPAT, IC, WACC, CC and EVA
PT.制药公司和SIDO制药的财务业绩分析出现了TBK
摘要对公司的财务绩效进行评估,是帮助管理层和投资者进行决策的重要手段。分析公司财务绩效评估的一种方法是使用经济增加值(EVA)分析法。EVA是一种用发行资金成本减去经济利润来确定公司增加值的分析方法。EVA法分析首先计算税后净营业利润(NOPAT)、投资资本(IC)、加权平均资本成本(WACC)、资本费用(CC)和经济增加值(EVA)。本研究旨在利用经济增加值(EVA)分析方法评估PT. Sido Muncul's Herbal and Pharmaceutical Industry, 2017-2019年的财务绩效。这项研究是描述性的,并使用了定量的方法。本研究的数据是财务报表,即资产负债表和损益表。从研究结果来看,研究年度的EVA值有所增加,且为正(EVA > 0),这表明Sido Muncul Tbk的PT. the Herbal and Pharmaceutical Industry of Sido Muncul Tbk能够为管理层和投资者(股东)创造附加经济价值。与同类公司比较,EVA值最高的是PT. Kalbe Farma Tbk,其次是PT. Herbal and Pharmaceutical Industry Sido Muncul Tbk,最后是PT Darya-Varia Laboratoria Tbk。关键词:财务报表分析,NOPAT, IC, WACC, CC, EVA
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信